AI Verdict
CVS has stronger fundamentals based on our AI analysis.
COR vs CVS Fundamental Comparison
| Metric | COR | CVS |
|---|---|---|
| Revenue | $85.9B | $402.1B |
| Net Income | $559.6M | $1.8B |
| Net Margin | 0.7% | 0.4% |
| ROE | 29.3% | 2.4% |
| ROA | 0.7% | 0.7% |
| Current Ratio | 0.92x | 0.84x |
| Debt/Equity | 4.15x | 0.85x |
| EPS | $2.87 | $1.39 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
COR vs CVS: Frequently Asked Questions
Is COR or CVS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), CVS has stronger fundamentals. COR is rated SELL (74% confidence) while CVS is rated HOLD (70% confidence). This is not investment advice.
How does COR compare to CVS fundamentally?
Cencora, Inc. has ROE of 29.3% vs CVS HEALTH Corp's 2.4%. Net margins are 0.7% vs 0.4% respectively.
Which stock pays higher dividends, COR or CVS?
COR has a dividend yield of N/A or no dividend while CVS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in COR or CVS for long term?
For long-term investing, consider that COR has SELL rating with 74% confidence, while CVS has HOLD rating with 70% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about COR vs CVS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For COR vs CVS, the AI consensus favors CVS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.